AmeriFlex Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

AmeriFlex Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587	Buy	+2	New	+$567	﹤0.01%	1486
2026 Q1	–	Sell	-19	Closed	-$5.76K	–	1122
2025 Q4	$5.76K	Sell	19 -19	-50%	-$5.93K	﹤0.01%	826
2025 Q3	$10.7K	Buy	+38	New	+$10.3K	﹤0.01%	766
2025 Q2	–	Sell	-5	Closed	-$1.22K	–	1077
2025 Q1	$1.22K	Hold	5	–	–	﹤0.01%	1188
2024 Q4	$1.8K	Buy	+5	New	+$1.7K	﹤0.01%	1061

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AmeriFlex Group's BIO Position: Q2 2026 in Review

AmeriFlex Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 2 shares worth $587. The stake represents ﹤0.01% of the portfolio and ranks #1486 among its holdings. This is a return to the name: AmeriFlex Group previously reported a position in BIO as recently as Q4 2025.

AmeriFlex Group first reported a position in BIO in Q4 2024 and has held it in 5 quarters since. The position peaked at $10.7K in Q3 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

AmeriFlex Group held 2 shares of Bio-Rad Laboratories Class A worth $587 as of Q2 2026.
Bio-Rad Laboratories Class A was a new AmeriFlex Group position in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1486 holding.
AmeriFlex Group first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 5 quarters since.
AmeriFlex Group's Bio-Rad Laboratories Class A position peaked at $10.7K in Q3 2025.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.